Although it remains uncertain whether CD8+ T cells with these TCRs serve as a pathogenic source of IL-17 in the inflamed joints of AS patients, this scenario is possible since the number of IL-17-producing CD8+ T (Tc17) cells is greater in the gut of IBD patients than in that of healthy controls [145–147]. The gene discussed is IL17A; the disease is inflammatory bowel disease.